Lobular carcinoma in situ

  title={Lobular carcinoma in situ},
  author={N. Afonso and D. Bouwman},
  journal={European Journal of Cancer Prevention},
  • N. Afonso, D. Bouwman
  • Published 2008
  • Medicine
  • European Journal of Cancer Prevention
  • The diagnosis of lobular carcinoma in situ (LCIS) provokes considerable anxiety in patients owing to misconceptions about this diagnosis. Initially LCIS was considered a premalignant lesion, but it is now a marker of increased risk. The number of women diagnosed with LCIS has increased in recent years most likely owing to more rigorous breast cancer screening. Implications of this diagnosis and management options are discussed in this review. 
    41 Citations
    Molecular drivers of lobular carcinoma in situ
    • 28
    Assessment and management of B3 breast lesions with atypia: a focused review
    • 1
    Lobular Neoplasia of the Breast
    • 19
    Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
    • M. Hussain, G. Cunnick
    • Medicine
    • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
    • 2011
    • 90
    • PDF
    Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: A case report
    • 5
    The Evolution of Lobular Neoplasia
    • M. Lerwill
    • Medicine
    • Advances in anatomic pathology
    • 2006
    • 15


    Lobular Carcinoma In Situ of the Breast
    • 123